Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001493152-20-024073

CEO gave up 170 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Wolff Allen · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-19 Shares withheld for taxes : show line 1 in the form −170 $2.17 $369 141,865 D
Loading xslF345X03/ownership.xml…